Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Ajanta Pharma: Board Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended 31St December 2024.
News Announcement

Ajanta Pharma: Board Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended 31St December 2024.

17-Jan-2025 Follow Value Research Online on Google download pdfDownload PDF Ajanta Pharma

AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve Unaudited consolidated & standalone financial results of the Company for the third quarter and nine months ended 31st December 2024

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month